[{"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-001", "question": "A 3-week-old male infant presents with progressive jaundice, acholic stools, and hepatomegaly. Laboratory studies reveal total bilirubin 12.4 mg/dL (direct 9.8 mg/dL), GGT 890 U/L, and ALT 156 U/L. Abdominal ultrasound shows absence of the gallbladder and a triangular cord sign at the porta hepatis. HIDA scan demonstrates good hepatic uptake but no intestinal excretion at 24 hours. Intraoperative cholangiogram confirms biliary atresia. The Kasai portoenterostomy is performed at 28 days of life. Which of the following findings at the time of surgery most strongly predicts failure to achieve bile drainage and need for liver transplantation within 2 years?", "options": ["Presence of bile duct remnants less than 150 micrometers in diameter at the porta hepatis", "Bridging fibrosis on liver biopsy without established cirrhosis", "Cytomegalovirus IgM positivity in the infant", "Splenic malformation syndrome with polysplenia", "Absence of the common bile duct with patent proximal hepatic ducts"], "answer": "A", "answer_index": 0, "explanation": "The diameter of bile duct remnants at the porta hepatis is the strongest histopathologic predictor of successful bile drainage after Kasai portoenterostomy. Remnants less than 150 micrometers are associated with poor outcomes and early transplant need. Bridging fibrosis without cirrhosis does not preclude successful drainage. CMV-associated biliary atresia and splenic malformation syndrome have variable outcomes but are not as predictive as duct remnant size. Absence of common bile duct with patent proximal ducts actually suggests a more favorable anatomy.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed128.jsonl", "pred": "A", "model_outputs": "The clinical presentation is consistent with Biliary Atresia (BA). The infant has undergone a timely Kasai portoenterostomy (at 28 days of life, which is a favorable prognostic factor). The question identifies findings at the time of surgery that predict the *failure* to achieve bile drainage (clearance of jaundice) and the subsequent need for liver transplantation.\n\nAnalysis of Options:\n\n*   A. Presence of bile duct remnants less than 150 micrometers in diameter at the porta hepatis: The success of the Kasai portoenterostomy (hepatic portoenterostomy) depends fundamentally on the presence of patent microscopic bile ductules in the fibrous tissue at the porta hepatis that can communicate with the intrahepatic biliary tree and drain bile into the Roux-en-Y loop. Multiple specific histopathological studies (notably the Ohi classification) have established that the diameter of these ductules is a critical prognostic factor. Remnants with a diameter greater than 150 µm are associated with successful bile flow. Conversely, the absence of ductules or the presence of only tiny remnants (< 150 µm) is a very strong predictor of poor bile flow and failure of the procedure.\n\n*   B. Bridging fibrosis on liver biopsy without established cirrhosis: While the extent of liver fibrosis is a prognostic factor (cirrhosis/stage 4 fibrosis implies a poor outcome), bridging fibrosis (stage 3) is commonly seen in infants with BA and does not preclude successful bile drainage, especially when surgery is performed early (as in this 28-day-old infant). Established cirrhosis would be a stronger predictor, but bridging fibrosis alone is not the strongest predictor of failure compared to the anatomical absence of drainable ducts.\n\n*   C. Cytomegalovirus IgM positivity in the infant: CMV-associated biliary atresia is a distinct clinical group often associated with older age at presentation and greater inflammation. While CMV positivity is generally considered a negative prognostic factor regarding native liver survival, the data on jaundice clearance is variable, and it is not as direct or absolute a mechanical predictor of surgical failure as the ductal anatomy.\n\n*   D. Splenic malformation syndrome with polysplenia: This refers to Biliary Atresia Splenic Malformation (BASM) syndrome. While infants with BASM often have associated cardiac anomalies that contribute to higher overall mortality, large cohort studies (e.g., by Davenport et al.) have suggested that the rate of successful bile dosage/jaundice clearance after Kasai in BASM patients is comparable to or only slightly lower than that in isolated BA. Therefore, it is not the strongest predictor of *failure to drain* specifically.\n\n*   E. Absence of the common bile duct with patent proximal hepatic ducts: This describes a \"correctable\" type of biliary atresia (Type I or II), where the obstruction is distal and the proximal ducts are patent. This finding allows for a direct biliary-enteric anastomosis (hepaticoduodenostomy or jejunostomy) to patent ducts and is associated with a high success rate and good prognosis. Thus, this predicts success, not failure.\n\nConclusion: The presence of sufficiently sized microscopic ductules is the anatomical prerequisite for the Kasai procedure to work. The lack thereof (remnants < 150 µm) makes drainage mechanistically unlikely.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-002", "question": "A 34-year-old woman is brought to the emergency department after a house fire. She was found unconscious in a closed room. On arrival, she is obtunded with GCS 8. Vital signs: BP 142/88 mmHg, HR 118 bpm, RR 28/min, SpO2 98% on 100% FiO2 via non-rebreather mask. Physical examination reveals cherry-red skin coloration, no visible burns, and no soot in the oropharynx. Arterial blood gas on 100% oxygen shows pH 7.18, PaCO2 28 mmHg, PaO2 487 mmHg, lactate 14 mmol/L. Carboxyhemoglobin level is 8%. Co-oximetry reveals an additional abnormal hemoglobin species at 18%. Which of the following is the most appropriate next step in management?", "options": ["Emergent hyperbaric oxygen therapy", "Intravenous hydroxocobalamin 5 grams", "Methylene blue 1-2 mg/kg intravenously", "Exchange transfusion", "Sodium thiosulfate 12.5 grams intravenously"], "answer": "B", "answer_index": 1, "explanation": "The clinical presentation with severe lactic acidosis, obtundation, relatively low carboxyhemoglobin but an additional abnormal hemoglobin species (18% methemoglobin-like reading which actually represents cyanohemoglobin on co-oximetry) in a fire victim strongly suggests cyanide toxicity from combustion of synthetic materials. Hydroxocobalamin is the first-line antidote for cyanide poisoning as it directly binds cyanide to form cyanocobalamin. Hyperbaric oxygen addresses CO toxicity but CO level is only 8%. Methylene blue treats methemoglobinemia but is contraindicated with cyanide. Sodium thiosulfate is slower acting and used as adjunct therapy.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "abms_specialty": "Emergency Medicine", "abms_source": "target_topic", "source_label_raw": "Emergency Medicine", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed128.jsonl", "pred": "B", "model_outputs": "This patient presents with a clinical picture characteristic of severe cyanide poisoning secondary to smoke inhalation in a closed-space fire.\n\n1.  Diagnosis:\n    *   Clinical Context: House fire, closed room, unconsciousness (GCS 8).\n    *   Laboratories: The most telling finding is the severe lactic acidosis (Lactate 14 mmol/L). In the context of smoke inhalation, a lactate level > 10 mmol/L is highly sensitive and specific for cyanide poisoning (which inhibits mitochondrial cytochrome oxidase, forcing anaerobic metabolism).\n    *   Physical Exam: \"Cherry-red skin\" is classically described in Carbon Monoxide (CO) poisoning but can also be seen in Cyanide poisoning (due to high venous oxygen content from failed tissue extraction).\n    *   Data Interpretation:\n        *   Carboxyhemoglobin (COHb) is 8%. While elevated, this level is far too low to explain the coma and severe metabolic acidosis (severe CO toxicity typically typically occurs at > 25-40%).\n        *   Abnormal Hemoglobin Species (18%): This likely represents Methemoglobin (MetHb), which can result from inhaling oxides of nitrogen in fires. However, a MetHb level of 18% typically causes only cyanosis and is generally asymptomatic or causes mild symptoms (headache, anxiety). It does not explain the coma or the profound lactic acidosis.\n\n2.  Management:\n    *   The immediate threat to life is the Cyanide poisoning, indicated by the coma and massive lactate.\n    *   Option B (Hydroxocobalamin): This is the first-line antidote for suspected cyanide poisoning. It binds cyanide avidly to form cyanocobalamin (Vitamin B12), which is nontoxic and excreted in the urine. It is preferred over the older Cyanide Antidote Kit (Amyl nitrite/Sodium nitrite) in fire victims because nitrites induce methemoglobinemia. Since this patient already has a MetHb level of 18% and concomitant CO exposure (decreasing O2 carrying capacity), inducing further MetHb with nitrites could be fatal. Hydroxocobalamin does not compromise oxygen-carrying capacity.\n    *   Option A (HBO): Indicated for severe CO poisoning. With COHb of 8%, this is not the priority.\n    *   Option C (Methylene Blue): Used for symptomatic Methemoglobinemia (usually levels > 30%). Treating an 18% MetHb level is not the priority over the lethal cyanide toxicity.\n    *   Option E (Sodium Thiosulfate): Acts as a sulfur donor for the enzyme rhodanese to detoxify cyanide. It is effective but has a slower onset of action compared to hydroxocobalamin. It is often used as an adjunct, but Hydroxocobalamin is the \"single best\" initial emergent therapy given the GCS of 8.\n\nThe correct choice addresses the most lethal pathology (Cyanide) with the safest and most effective antidote.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-003", "question": "A 28-year-old woman at 32 weeks gestation presents with sudden onset severe headache, visual disturbances, and confusion. Blood pressure is 178/112 mmHg. Laboratory studies show platelets 68,000/μL, LDH 890 U/L, AST 245 U/L, creatinine 1.8 mg/dL, and peripheral smear with schistocytes. She receives magnesium sulfate and labetalol. Emergent cesarean delivery is performed. Postpartum day 3, despite delivery, her platelet count drops to 42,000/μL, creatinine rises to 2.9 mg/dL, and she develops new neurological symptoms. ADAMTS13 activity returns at 58%. Which additional finding would most strongly support initiating eculizumab therapy?", "options": ["Positive direct antiglobulin test", "Complement factor H mutation on genetic testing", "Elevated soluble fms-like tyrosine kinase-1 levels", "Low C3 with normal C4 levels", "Presence of anti-phospholipid antibodies"], "answer": "B", "answer_index": 1, "explanation": "This presentation of postpartum thrombotic microangiopathy not resolving after delivery with ADAMTS13 >10% suggests complement-mediated TMA (atypical HUS) rather than TTP or HELLP syndrome. Complement factor H mutation confirms complement dysregulation and strongly supports eculizumab (C5 inhibitor) therapy. Low C3 with normal C4 suggests alternative pathway activation but is nonspecific. Elevated sFlt-1 would suggest ongoing preeclampsia-related pathology. Positive DAT would suggest Evans syndrome, and anti-phospholipid antibodies suggest catastrophic APS, both requiring different management.", "generator_model": "claude-opus-4-5-20251101", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "abms_specialty": "Obstetrics and Gynecology", "abms_source": "topics_mapped", "source_label_raw": "obstetrics", "source_quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed124", "source_question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed124-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251129T135352000Z_claude-opus-4-5-20251101_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251129T135352000Z_claude-opus-4-5-20251101_seed124.jsonl", "pred": "B", "model_outputs": "The clinical presentation is consistent with a Thrombotic Microangiopathy (TMA). The patient initially presented with features resembling severe preeclampsia or HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) and underwent delivery. The key feature differentiating this case from typical HELLP syndrome is the clinical worsening (falling platelets, rising creatinine, new neurological deficit) on postpartum day 3. HELLP syndrome typically resolves or begins to improve within 24-48 hours after delivery.\n\nThe persistence and worsening of the TMA suggest an alternative diagnosis, most notably Atypical Hemolytic Uremic Syndrome (aHUS) or Thrombotic Thrombocytopenic Purpura (TTP). The ADAMTS13 activity is 58%, which rules out TTP (defined by activity <10%). This leaves aHUS (complement-mediated TMA) as the most likely diagnosis, especially given the pregnancy trigger.\n\nEculizumab is a monoclonal antibody that inhibits terminal complement activation (C5) and is the treatment of choice for aHUS.\n\nEvaluating the options:\n*   A. Positive direct antiglobulin test (DAT): This would suggest autoimmune hemolytic anemia (AIHA) or SLE, not a primary TMA like aHUS.\n*   B. Complement factor H mutation on genetic testing: Mutations in complement regulatory genes (Factor H, Factor I, MCP) are the underlying cause of aHUS. Factor H mutations are the most common. Finding a pathogenic mutation definitively confirms the diagnosis of complement-mediated TMA and provides the strongest mechanistic support for using a complement inhibitor like eculizumab.\n*   C. Elevated soluble fms-like tyrosine kinase-1 (sFlt-1) levels: Significantly elevated sFlt-1 levels are characteristic of placenta-mediated complications like Preeclampsia/HELLP. In the differential diagnosis of TMA in pregnancy, a *normal* or low sFlt-1/PlGF ratio would favor a diagnosis of aHUS or TTP over HELLP. An elevated level supports the diagnosis of HELLP syndrome (which is treated with delivery and supportive care), making this a poor supporter for initiating eculizumab compared to a specific marker for aHUS.\n*   D. Low C3 with normal C4 levels: This complement profile suggests activation of the alternative complement pathway, consistent with aHUS. However, normal C3 levels are seen in 30-50% of patients with aHUS, and low C3 can be seen in other conditions (like infection or glomerulonephritis). While supportive, it is less definitive than a genetic mutation.\n*   E. Presence of anti-phospholipid antibodies: This would support a diagnosis of Catastrophic Antiphospholipid Syndrome (CAPS), which is primarily treated with anticoagulation, corticosteroids, and plasma exchange.\n\nTherefore, the finding that most strongly establishes the diagnosis of aHUS and supports the specific use of eculizumab is the genetic mutation.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-004", "question": "A 58-year-old man with a history of chronic alcohol use disorder is undergoing emergency laparotomy for perforated duodenal ulcer. He received 4 units of packed red blood cells and 2 units of fresh frozen plasma intraoperatively. Thirty minutes after induction with propofol, fentanyl, and rocuronium, the anesthesiologist notes progressive hypotension (MAP 52 mmHg), tachycardia (128 bpm), elevated peak airway pressures (42 cmH2O), and oxygen desaturation to 88%. Central venous pressure has increased from 6 to 18 mmHg. There is no urticaria or angioedema. Bronchospasm is noted on auscultation. Serum tryptase drawn at this time returns elevated at 48 ng/mL (normal <11.4). Which of the following mechanisms most likely explains this patient's reaction?", "options": ["IgE-mediated mast cell degranulation to latex proteins", "Complement activation by anti-IgA antibodies", "Direct mast cell activation by neuromuscular blocking agent", "Bradykinin accumulation from C1-esterase inhibitor deficiency", "Transfusion-related acute lung injury from donor anti-HLA antibodies"], "answer": "C", "answer_index": 2, "explanation": "Neuromuscular blocking agents, particularly rocuronium, are the most common cause of perioperative anaphylaxis. They can cause direct (non-IgE mediated) mast cell degranulation through MRGPRX2 receptor activation, which explains the elevated tryptase, bronchospasm, and cardiovascular collapse without prior sensitization. IgA deficiency reactions typically present with urticaria and occur during transfusion. TRALI causes non-cardiogenic pulmonary edema without elevated tryptase or bronchospasm. Bradykinin-mediated angioedema does not cause bronchospasm or elevated tryptase. Latex allergy is less common and typically requires mucosal contact.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "abms_specialty": "Anesthesiology", "abms_source": "target_topic", "source_label_raw": "Anesthesiology", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed128.jsonl", "pred": "A", "model_outputs": "The clinical presentation of hypotension, tachycardia, bronchospasm (elevated peak airway pressures), and oxygen desaturation is highly suggestive of intraoperative anaphylaxis. The elevated serum tryptase confirms mast cell degranulation, which rules out mechanisms such as bradykinin-mediated angioedema (Option D) and Transfusion-Related Acute Lung Injury (TRALI, Option E), as tryptase is normal in these conditions.\n\nThe key to distinguishing the cause lies in the timing of the reaction:\n1.  Neuromuscular Blocking Agents (NMBAs) (e.g., Rocuronium) and Antibiotics: Reactions typically occur immediately (within minutes) upon administration during induction.\n2.  Latex: Reactions are typically delayed (onset 30–60 minutes after the start of the procedure). This delay occurs because latex proteins from gloves, catheters, or drains require time to be absorbed through skin, mucous membranes, or the peritoneum to reach a threshold for triggering systemic anaphylaxis.\n3.  Blood Products: Anaphylactic reactions to blood (e.g., in IgA deficiency) usually happen very rapidly after the start of the transfusion (after only a few milliliters are infused).\n\nIn this scenario, the reaction occurred 30 minutes after induction. This timing is classic for latex anaphylaxis. Furthermore, regarding Option C, Rocuronium causes anaphylaxis primarily via an IgE-mediated mechanism, not direct mast cell activation (unlike benzylisoquinolines like atracurium which can cause direct histamine release). Thus, Option C describes an incorrect mechanism for the drug and an incorrect timeline. Option B is unlikely because anaphylaxis to blood is typically immediate upon exposure, and the timing presented specifically aligns with the latex absorption window.\n\nTherefore, the most likely mechanism is IgE-mediated mast cell degranulation to latex proteins.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-005", "question": "A 28-year-old woman with treatment-resistant schizophrenia has been on clozapine 450 mg daily for 8 months with good symptom control. She presents with fever (39.2°C), sore throat, and malaise for 2 days. Laboratory studies reveal WBC 1,200/μL with absolute neutrophil count (ANC) 180/μL, hemoglobin 11.2 g/dL, and platelets 198,000/μL. Clozapine is immediately discontinued. After 14 days of supportive care including G-CSF, her ANC recovers to 2,400/μL. Given her excellent prior response to clozapine, the treatment team considers rechallenge. Which of the following factors most strongly contraindicates clozapine rechallenge in this patient?", "options": ["ANC nadir below 500/μL during the index episode", "Duration of neutropenia exceeding 10 days", "Concurrent use of G-CSF during recovery", "Time to ANC recovery exceeding 21 days from clozapine discontinuation", "Presence of fever during the neutropenic episode"], "answer": "A", "answer_index": 0, "explanation": "An ANC nadir below 500/μL (severe neutropenia/agranulocytosis) during clozapine-induced neutropenia is an absolute contraindication to rechallenge according to FDA guidelines and the Clozapine REMS program. Patients with ANC that dropped below 500/μL have a significantly higher risk of recurrent severe neutropenia with rechallenge. Duration of neutropenia, G-CSF use, recovery time, and presence of fever are concerning but do not absolutely contraindicate rechallenge if the nadir remained above 500/μL. The severity of the nadir is the critical determinant.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "abms_specialty": "Psychiatry", "abms_source": "target_topic", "source_label_raw": "Psychiatry", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed128.jsonl", "pred": "A", "model_outputs": "Clozapine-induced agranulocytosis is defined as an Absolute Neutrophil Count (ANC) of less than 500/μL. Standard treatment guidelines (such as the US Clozapine REMS and the manufacturer's labeling) designate an ANC < 500/μL as severe neutropenia and list it as a contraindication to rechallenge (marked as \"Do Not Restart\").\n\nWhile rechallenge is sometimes attempted off-label in treatment-resistant cases under strict hematology supervision, the most significant predictor of rechallenge failure and risk is the severity of the index episode. Specifically, patients who experienced true agranulocytosis (ANC < 500/μL) have a significantly higher rate of recurrence and a shorter latency to recurrence upon rechallenge compared to patients who only experienced moderate neutropenia (ANC 500–1000/μL). Therefore, the depth of the nadir is the primary factor limiting rechallenge.\n\nLet's evaluate the other options:\n*   B (Duration > 10 days): While a longer duration of neutropenia indicates more profound marrow suppression, the regulatory and primary clinical \"hard stop\" is defined by the ANC threshold (< 500/μL).\n*   C (G-CSF use): G-CSF is a standard treatment for clozapine-induced agranulocytosis and does not contraindicate future rechallenge; in fact, it is often part of the protocol for supporting a rechallenge.\n*   D (Time to recovery > 21 days): A very prolonged recovery (e.g., > 30 days) suggests marrow failure and is a strong relative contraindication. However, this patient recovered in 14 days, so this factor does not apply to her.\n*   E (Presence of fever): Fever indicates the episode was complicated (febrile neutropenia), which increases immediate morbidity, but the biological contraindication for the drug is the immune-mediated destruction of neutrophils (ANC < 500/μL). An afebrile patient with ANC of 180 would also be contraindicated for rechallenge.\n\nTherefore, the fact that her ANC dropped below the threshold of 500/μL is the strongest standard contraindication.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-006", "question": "A 67-year-old man undergoes elective right hemicolectomy for a cecal adenocarcinoma. On postoperative day 3, he develops fever (38.9°C), tachycardia, and diffuse abdominal tenderness with guarding. CT scan reveals free air, a 4-cm fluid collection near the ileocolic anastomosis, and no contrast extravasation on oral contrast study. Laboratory studies show WBC 18,400/μL and lactate 3.2 mmol/L. At re-exploration, the anastomosis appears intact but edematous with surrounding fibrinous exudate. There is 400 mL of turbid fluid in the peritoneal cavity. Gram stain of the fluid shows gram-negative rods and gram-positive cocci in chains. Which of the following is the most appropriate surgical management?", "options": ["Washout with drain placement and preservation of anastomosis", "Takedown of anastomosis with end ileostomy and mucous fistula", "Takedown of anastomosis with end ileostomy and Hartmann's pouch", "Resection of anastomosis with primary re-anastomosis and proximal diverting loop ileostomy", "Washout with omental patch reinforcement of anastomosis"], "answer": "B", "answer_index": 1, "explanation": "This patient has an anastomotic leak with peritonitis despite the anastomosis appearing grossly intact (contained leak with surrounding contamination). In the setting of generalized peritonitis, hemodynamic compromise (tachycardia, elevated lactate), and polymicrobial contamination, the safest approach is takedown of the anastomosis with end ileostomy and mucous fistula. This is preferred over Hartmann's pouch because the distal bowel (ascending/transverse colon) is healthy and can be exteriorized. Preserving the anastomosis or performing primary re-anastomosis in this contaminated, inflamed field carries unacceptable leak risk.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "abms_specialty": "General Surgery", "abms_source": "target_topic", "source_label_raw": "General Surgery", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed128.jsonl", "pred": "B", "model_outputs": "This patient presents with signs of an anastomotic leak following a right hemicolectomy (fever, tachycardia, abdominal pain, leukocytosis, elevated lactate) and generalized peritonitis (diffuse tenderness, guarding, turbid fluid in the abdomen). Although the anastomosis appeared \"intact\" on inspection, the presence of edematous tissue, fibrinous exudate, and infected fluid (Gram stain showing enteric flora) confirms the diagnosis. The elevated lactate and clinical instability indicate sepsis.\n\nThe surgical management of an anastomotic leak depends on the patient's clinical status and the degree of contamination.\n1.  Stable patient, contained leak (abscess): Percutaneous drainage or antibiotics.\n2.  Unstable patient or generalized peritonitis: Surgical re-exploration is required.\n\nAt re-exploration for generalized peritonitis:\n*   Preservation of the anastomosis (Option A) with washout and drainage is associated with a high failure and mortality rate in the setting of generalized peritonitis and sepsis. The source of infection (the leaking anastomosis) must be controlled.\n*   Resection and re-anastomosis (Option D) is contraindicated in the presence of gross inflammation and purulent peritonitis due to the extremely high risk of recurrent leak.\n*   Takedown of the anastomosis is the safest course of action to ensure source control. This results in an end ileostomy.\n\nRegarding the management of the distal limb (transverse colon):\n*   Option B (Mucous fistula): Bringing the distal transverse colon to the skin as a mucous fistula minimizes the risk of an intraperitoneal leak from a suture line in an infected field. This is the most conservative and safest approach in a septic patient, as it exteriorizes all bowel ends.\n*   Option C (Hartmann's pouch): This involves stapling/suturing the distal bowel and leaving it in the abdomen. While often done if the colon is too short to reach the skin, the term \"Hartmann's pouch\" strictly refers to a closed rectal stump. Furthermore, leaving a staple line in a purulent abdomen carries a risk (albeit low for the colon) of stump dehiscence. Option B avoids this risk entirely.\n\nTherefore, the most appropriate and safest management for a septic patient with generalized peritonitis from a right-sided anastomotic leak is taking down the anastomosis, creating a proximal end ileostomy, and exteriorizing the distal limb as a mucous fistula.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-007", "question": "A 58-year-old man with type 2 diabetes presents with sudden painless vision loss in his right eye upon awakening. Best-corrected visual acuity is 20/200 OD and 20/25 OS. Funduscopic examination of the right eye reveals diffuse retinal whitening with a cherry-red spot at the macula, attenuated arterioles, and segmentation of blood columns (\"boxcarring\"). Intraocular pressure is 14 mmHg OD and 15 mmHg OS. Carotid duplex shows 40% stenosis of the right internal carotid artery. Echocardiogram reveals no intracardiac thrombus. The patient presents 3 hours after symptom onset. Which of the following interventions has the strongest evidence for visual recovery in this condition?", "options": ["Anterior chamber paracentesis to lower intraocular pressure", "Intravenous tissue plasminogen activator", "Hyperbaric oxygen therapy", "Intra-arterial thrombolysis via ophthalmic artery catheterization", "Conservative management with secondary stroke prevention"], "answer": "E", "answer_index": 4, "explanation": "This patient has central retinal artery occlusion (CRAO). Despite numerous proposed interventions including ocular massage, anterior chamber paracentesis, carbogen inhalation, IV or intra-arterial thrombolysis, and hyperbaric oxygen, no treatment has demonstrated consistent efficacy in randomized controlled trials for improving visual outcomes in CRAO. The EAGLE study found no benefit of intra-arterial thrombolysis. Current evidence supports conservative management with urgent evaluation and treatment for stroke risk factors, as CRAO is considered a stroke equivalent. Secondary prevention with antiplatelet therapy and risk factor modification is the evidence-based approach.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "abms_specialty": "Ophthalmology", "abms_source": "target_topic", "source_label_raw": "Ophthalmology", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-010", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed128.jsonl", "pred": "B", "model_outputs": "The clinical presentation is consistent with a Central Retinal Artery Occlusion (CRAO). The patient presents with sudden painless vision loss, and fundoscopy reveals the classic \"cherry-red spot\" and retinal whitening. The critical factor in this vignette is the time of presentation: 3 hours after symptom onset.\n\nTreatment options for CRAO have historically involved \"conservative\" measures such as anterior chamber paracentesis (A), ocular massage, and IOP-lowering medications to increase retinal perfusion pressure. However, multiple studies and systematic reviews have failed to demonstrate any greater visual recovery with these maneuvers compared to the natural history of the disease (spontaneous recovery).\n\nOption D (Intra-arterial thrombolysis) was investigated in the landmark EAGLE trial (2010), a randomized controlled trial (RCT). The study showed no significant improvement in visual outcomes compared to standard care and demonstrated a higher rate of adverse events (e.g., hemorrhage). Therefore, evidence supports *not* using this intervention.\n\nOption E (Conservative management) is the standard of care in many settings due to the lack of a proven, FDA-approved therapy. However, conservative management itself does not promote visual recovery; it focuses on secondary stroke prevention. The prompt specifically asks for the intervention with the strongest evidence for visual recovery.\n\nOption B (Intravenous tissue plasminogen activator - IV tPA) has been the subject of recent meta-analyses (e.g., Schrag et al., 2015; AHA Scientific Statement 2021). These studies suggest that IV tPA, when administered within a therapeutic window (typically <4.5 hours), is associated with significantly higher rates of visual recovery (approx. 50%) compared to conservative management (approx. 17%). While there is currently no completed Phase 3 RCT confirming this (trials like THEIA and RECOVER are ongoing or discussed), the AHA 2021 Scientific Statement on CRAO concludes that IV tPA within 4.5 hours is the most reasonable intervention to consider for visual recovery given the available observational and meta-analytic evidence, contrasting it with the inefficacy of conservative measures and the risks/inefficacy of intra-arterial tPA shown in EAGLE.\n\nGiven the 3-hour presentation window and the prompt asking for evidence *for* recovery (implying efficacy), IV tPA is the best answer among the choices.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-008", "question": "A 34-year-old professional baseball pitcher presents with progressive shoulder pain and weakness during the late cocking phase of throwing. MRI reveals a partial articular-sided supraspinatus tear with a posterosuperior labral tear. Physical examination demonstrates 145 degrees of external rotation and only 25 degrees of internal rotation in 90 degrees of abduction. The total arc of motion is preserved compared to the contralateral side. Which biomechanical adaptation is the PRIMARY contributor to this pathology?", "options": ["Anterior capsular laxity with increased humeral head translation", "Posterior capsular contracture with posterosuperior humeral head migration", "Scapular dyskinesis with altered glenohumeral kinematics", "Rotator cuff fatigue with dynamic superior humeral head migration", "Biceps tendon subluxation with altered force coupling"], "answer": "B", "answer_index": 1, "explanation": "This presentation describes glenohumeral internal rotation deficit (GIRD) with internal impingement syndrome. Posterior capsular contracture shifts the glenohumeral contact point posterosuperiorly during abduction and external rotation, causing the greater tuberosity to impinge on the posterosuperior labrum and articular surface of the rotator cuff. While anterior laxity and scapular dyskinesis may contribute, the primary biomechanical driver is posterior capsular tightness causing the characteristic GIRD pattern with preserved total arc of motion.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "abms_specialty": "Orthopedic Surgery", "abms_source": "target_topic", "source_label_raw": "Orthopedic Surgery", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed129.jsonl", "pred": "B", "model_outputs": "The clinical presentation is consistent with internal impingement (also known as posterosuperior impingement) in an overhead-throwing athlete. The patient exhibits typical signs, including shoulder pain in the late cocking phase, a partial articular-sided supraspinatus tear (PASTA lesion), and a posterosuperior labral tear. The physical examination reveals Glenohumeral Internal Rotation Deficit (GIRD), characterized by a significant loss of internal rotation (only 25 degrees) and increased external rotation, with a preserved total arc of motion.\n\nCurrent biomechanical theories, particularly those championed by Burkhart, Morgan, and Kibler, attribute this pathology primarily to posterior capsular contracture. The tightness of the posterior inferior capsule alters glenohumeral kinematics. Specifically, during the late cocking phase of throwing (abduction and external rotation), the tight posterior capsule acts as a tether, forcing the humeral head to translate posterosuperiorly away from the axillary pouch. This migration increases the contact and shear forces between the undersurface of the rotator cuff (supraspinatus/infraspinatus) and the posterosuperior glenoid labrum, leading to the observed tears.\n\nWhile anterior laxity (Option A) was historically proposed as a cause, contemporary studies (e.g., Grossman et al.) support the posterior capsular contracture model as the primary driver of the pathologic kinematics in internal impingement. The preservation of the total arc of motion suggests bony retroversion contributes to the range of motion shift, but the pathologic forces generating the tears are linked to the altered kinematics (posterosuperior migration) driven by posterior restraint phenomena.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-009", "question": "A 72-year-old man is admitted to the ICU with septic shock from pneumonia. Despite adequate fluid resuscitation and norepinephrine at 0.5 mcg/kg/min, MAP remains 58 mmHg. Echocardiography shows hyperdynamic left ventricle with EF 75%, small LV cavity, and IVC diameter of 0.8 cm with >50% respiratory variation. Lactate is 6.2 mmol/L. Which vasopressor strategy is most appropriate?", "options": ["Add vasopressin 0.03 units/min", "Add epinephrine infusion", "Add phenylephrine infusion", "Add angiotensin II infusion", "Increase norepinephrine to maximum dose before adding second agent"], "answer": "A", "answer_index": 0, "explanation": "Current sepsis guidelines recommend adding vasopressin (up to 0.03 units/min) as the second-line vasopressor when norepinephrine fails to achieve target MAP, typically when norepinephrine exceeds 0.25-0.5 mcg/kg/min. Vasopressin acts via V1 receptors independent of catecholamine pathways, which may be downregulated in sepsis. The VASST trial showed potential mortality benefit in less severe septic shock. The echocardiographic findings suggest adequate volume status (small IVC with variation indicates fluid responsiveness is exhausted). Angiotensin II is reserved for refractory vasodilatory shock after multiple agents. Phenylephrine may reduce cardiac output.", "generator_model": "claude-opus-4-5-20251101", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Critical Care Medicine", "abms_specialty": "Critical Care Medicine", "abms_source": "topics_mapped", "source_label_raw": "critical care", "source_quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed126", "source_question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed126-007", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251129T135352000Z_claude-opus-4-5-20251101_seed126", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251129T135352000Z_claude-opus-4-5-20251101_seed126.jsonl", "pred": "A", "model_outputs": "The clinical scenario describes a patient in septic shock with refractory hypotension (MAP 58 mmHg) despite a high dose of norepinephrine (0.5 mcg/kg/min). The echocardiogram reveals a hyperdynamic left ventricle with a small cavity and signs of fluid responsiveness (small, collapsible IVC), which is consistent with significant vasodilation and relative or absolute hypovolemia (\"empty tank\"). However, the question asks for the appropriate *vasopressor strategy* given that fluid resuscitation has been deemed \"adequate\" (likely implying the standard boluses were given, and the patient is now in a refractory vasodilatory state or limited by pulmonary concerns).\n\n1.  Guideline Recommendation: The Surviving Sepsis Campaign guidelines recommend adding vasopressin (up to 0.03 units/min) to norepinephrine when the MAP target is not achieved with moderate-to-high doses of norepinephrine (typically 0.25–0.5 mcg/kg/min). This is intended to raise MAP and \"spare\" the norepinephrine dose, reducing the risk of catecholamine-induced adverse events (arrhythmias, ischemia).\n2.  Echo Findings: The hyperdynamic LV and small cavity suggest a high-contractile state. Adding agents with beta-adrenergic activity (inotropes) like epinephrine (Option B) or increasing norepinephrine (Option E) significantly would be deleterious. They would increase myocardial oxygen demand, potentially worsen dynamic left ventricular outflow tract obstruction (if present due to the small cavity), and raise lactate levels.\n3.  Phenylephrine (Option C): While phenylephrine is a pure alpha-agonist and avoids beta-stimulation, vasopressin is the preferred second-line agent in septic shock guidelines due to the relative vasopressin deficiency often seen in septic shock and its ability to improve outcomes in terms of catecholamine sparing. Phenylephrine is typically reserved for patients with severe tachyarrhythmias or high cardiac output with low SVR who do not respond to other agents, but Vasopressin is the standard \"step 2\".\n4.  Angiotensin II (Option D): This is generally considered a third-line agent for vasodilatory shock.\n\nTherefore, adding vasopressin is the most appropriate next step in management.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-010", "question": "A 34-year-old man presents with progressive gait instability and cognitive decline over 18 months. Examination reveals vertical supranuclear gaze palsy, axial rigidity greater than limb rigidity, early postural instability with falls, and frontal release signs. Brain MRI shows midbrain atrophy with the 'hummingbird sign.' Genetic testing reveals a heterozygous mutation in the MAPT gene. His father died at age 45 with a similar presentation. Which tau isoform predominates in the neuropathological inclusions of this patient's condition?", "options": ["3-repeat tau (3R) exclusively", "4-repeat tau (4R) exclusively", "Mixed 3R and 4R tau in equal proportions", "Hyperphosphorylated tau without repeat domain specificity", "Truncated tau lacking the microtubule-binding domain"], "answer": "B", "answer_index": 1, "explanation": "This presentation describes progressive supranuclear palsy (PSP) phenotype associated with MAPT mutation. PSP is a 4-repeat (4R) tauopathy, with tau inclusions composed predominantly of 4R tau isoforms. Pick disease is characterized by 3R tau (A), while Alzheimer disease shows mixed 3R/4R tau (C). The tau in PSP is hyperphosphorylated but specifically 4R predominant, making (D) incomplete. Truncated tau (E) is not characteristic of PSP pathology.", "generator_model": "claude-opus-4-5-20251101", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "abms_specialty": "Neurology", "abms_source": "topics_mapped", "source_label_raw": "Neurology", "source_quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed123", "source_question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed123-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251129T135352000Z_claude-opus-4-5-20251101_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251129T135352000Z_claude-opus-4-5-20251101_seed123.jsonl", "pred": "B", "model_outputs": "This patient presents with a clinical syndrome characteristic of Progressive Supranuclear Palsy (PSP), evidenced by vertical supranuclear gaze palsy, axial rigidity, early postural instability with falls, and the \"hummingbird sign\" on MRI (indicating midbrain atrophy). While sporadic PSP is the most common form, the young age of onset (34 years) and strong family history with a known MAPT mutation indicate a hereditary form, often referred to as FTDP-17 (Frontotemporal Dementia with Parkinsonism linked to chromosome 17).\n\nHowever, the neuropathology is determined by the specific molecular effects of the mutation. MAPT mutations that present clinically as PSP typically involve the microtubule-binding region or affect the splicing of exon 10. Mutations that increase the inclusion of exon 10 lead to an overproduction of 4-repeat (4R) tau. Sporadic PSP and Corticobasal Degeneration (CBD) are classically defined as 4-repeat tauopathies, where the neurofibrillary tangles and glial inclusions (like tufted astrocytes in PSP) are composed of 4R tau.\n\nIn contrast:\n- 3-repeat (3R) tau predominates in Pick's disease (Option A).\n- Mixed 3R and 4R tau is characteristic of Alzheimer's disease (Option C).\n- Truncated tau is seen in some specific conditions but is not the primary defining feature of PSP (Option E).\n\nSince the patient's phenotype is PSP and PSP is a 4R tauopathy, the inclusions are predominantly (and in the context of exam classification, exclusively) 4R tau.\n\nThe answer is (B)"}]